Oxidative stress and myocardial gene alterations associated with doxorubicin-induced cardiotoxicity in rats persist for two months after treatment cessation - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Journal of Pharmacology and Experimental Therapeutics Année : 2011

Oxidative stress and myocardial gene alterations associated with doxorubicin-induced cardiotoxicity in rats persist for two months after treatment cessation

(1) , (2) , (1) , (1) , (3) , (1) , (1) , (1) , (1)
1
2
3

Résumé

The molecular mechanisms underlying doxorubicin (DOX)-induced cardiomyopathy include alterations in cardiomyocytes' oxidative stress status and in gene expression. Although such alterations have been reported during in vivo DOX treatment of animals, it remains to be clarified whether they persist after treatment cessation. To address this question, rats were injected with either saline (1 ml/kg/day i.p; control) or DOX (1 mg/kg/day i.p.) for 10 days, and 70 days later cardiac functional parameters were evaluated in vivo by left ventricular catheterization. Hearts were also harvested for histological analyses as well as measurements of oxidative stress parameters by various techniques and gene expression by quantitative polymerase chain reaction of markers of cardiac pathological remodeling, namely atrial natriuretic factor, myosin heavy chain β, vascular endothelial growth factor A (VEGF-A), and sarcoplasmic reticulum Ca(+2) ATPase. Compared with controls, DOX-treated rats displayed marked alterations in most parameters even 2 months after cessation of treatment. These included 1) lower left ventricular contractility (+dP/dt), 2) increased levels of plasma and myocardial oxidative stress markers, namely thiobarbituric acid reactive substances or dihydroethidium fluorescence, and 3) markedly altered transcript levels for all measured markers of cardiac remodeling, except VEGF-A. These changes correlated significantly with +dP/dt values assessed in the two groups of animals. In conclusion, this study demonstrated that as many as 2 months after cessation of DOX treatment cardiac alterations persisted, reflecting increased oxidative stress and pathological remodeling, the latter being linked to the development of contractile dysfunction.
Fichier principal
Vignette du fichier
ArticleJPETrevised2.pdf (344.06 Ko) Télécharger le fichier
Vignette du fichier
Figure1.pdf (72.61 Ko) Télécharger le fichier
Vignette du fichier
Figure2.pdf (86.29 Ko) Télécharger le fichier
Vignette du fichier
Figure3.pdf (97.47 Ko) Télécharger le fichier
Vignette du fichier
Figure4.pdf (37.83 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03435401 , version 1 (18-11-2021)

Identifiants

Citer

Carole Richard, Steliana Ghibu, Stéphanie Delemasure-Chalumeau, Jean-Claude Guilland, Christine Des Rosiers, et al.. Oxidative stress and myocardial gene alterations associated with doxorubicin-induced cardiotoxicity in rats persist for two months after treatment cessation. Journal of Pharmacology and Experimental Therapeutics, 2011, 339 (3), pp.807-814. ⟨10.1124/jpet.111.185892⟩. ⟨hal-03435401⟩
14 Consultations
24 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More